147 related articles for article (PubMed ID: 21534011)
1. Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy.
Kurihara C; Nishimura T; Nawata K; Kinoshita O; Hisagi M; Motomura N; Kyo S; Ono M
J Artif Organs; 2011 Sep; 14(3):249-52. PubMed ID: 21534011
[TBL] [Abstract][Full Text] [Related]
2. Recovery from anthracycline-induced cardiomyopathy with biventricular assist and valve repairs: A case report and literature review.
Takami Y; Hoshino N; Kato Y; Sakurai Y; Amano K; Higuchi Y; Tochii M; Ishida M; Ishikawa H; Takagi Y; Ozaki Y
Int J Artif Organs; 2018 Jul; 41(7):413-417. PubMed ID: 29806528
[TBL] [Abstract][Full Text] [Related]
3. [Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use].
Berends M; van Bokhoven MM; van de Luijtgaarden A; Bellersen LB; van Hoesel QC; van Herpen CM
Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2088-92. PubMed ID: 18837186
[TBL] [Abstract][Full Text] [Related]
4. Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy.
Nasseri BA; Kukucka M; Dandel M; Knosalla C; Potapov E; Lehmkuhl HB; Meyer R; Ebell W; Stamm C; Hetzer R
Cell Transplant; 2007; 16(9):941-9. PubMed ID: 18293893
[TBL] [Abstract][Full Text] [Related]
5. Case report and review of the literature: the utilisation of a ventricular assist device as bridge to recovery for anthracycline-induced ventricular dysfunction.
Krasnopero D; Asante-Korang A; Jacobs JP; Stapleton S; Carapellucci J; Dotson M; Stapleton G
Cardiol Young; 2018 Mar; 28(3):471-475. PubMed ID: 29198224
[TBL] [Abstract][Full Text] [Related]
6. Triple-site pacing: a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy.
Nishimura T; Kyo S
J Artif Organs; 2010 Apr; 13(1):54-7. PubMed ID: 20174955
[TBL] [Abstract][Full Text] [Related]
7. Remission of chronic anthracycline-induced heart failure with support from a continuous-flow left ventricular assist device.
Khan N; Husain SA; Husain SI; Khalaf N; George J; Raissi F; Segura AM; Kar B; Bogaev RC; Frazier OH
Tex Heart Inst J; 2012; 39(4):554-6. PubMed ID: 22949777
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.
Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
Tex Heart Inst J; 2015 Apr; 42(2):124-30. PubMed ID: 25873821
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device as bridge to recovery for anthracycline-induced terminal heart failure.
Appel JM; Sander K; Hansen PB; Møller JE; Krarup-Hansen A; Gustafsson F
Congest Heart Fail; 2012; 18(5):291-4. PubMed ID: 22521037
[TBL] [Abstract][Full Text] [Related]
10. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
11. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.
Dandel M; Weng Y; Siniawski H; Stepanenko A; Krabatsch T; Potapov E; Lehmkuhl HB; Knosalla C; Hetzer R
Eur Heart J; 2011 May; 32(9):1148-60. PubMed ID: 20929978
[TBL] [Abstract][Full Text] [Related]
12. Acute chemotherapy-induced cardiomyopathy treated with intracorporeal left ventricular assist device in an 8-year-old child.
Schweiger M; Dave H; Lemme F; Cavigelli-Brunner A; Romanchenko O; Heineking B; Hofmann M; Bürki C; Stiasny B; Hübler M
ASAIO J; 2013; 59(5):520-2. PubMed ID: 23995994
[TBL] [Abstract][Full Text] [Related]
13. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
Demirozu ZT; Arat N; Kucukaksu DS
Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function.
Farrar DJ; Holman WR; McBride LR; Kormos RL; Icenogle TB; Hendry PJ; Moore CH; Loisance DY; El-Banayosy A; Frazier H
J Heart Lung Transplant; 2002 May; 21(5):516-21. PubMed ID: 11983540
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.
Guha A; Caraballo C; Jain P; Miller PE; Owusu-Guha J; Clark KAA; Velazquez EJ; Ahmad T; Baldassarre LA; Addison D; Weintraub NL; Desai NR
ESC Heart Fail; 2021 Aug; 8(4):2866-2875. PubMed ID: 33982867
[TBL] [Abstract][Full Text] [Related]
17. VAD as bridge to recovery in anthracycline-induced cardiomyopathy and HHV6 myocarditis.
Cavigelli-Brunner A; Schweiger M; Knirsch W; Stiasny B; Klingel K; Kretschmar O; Hübler M
Pediatrics; 2014 Sep; 134(3):e894-9. PubMed ID: 25092940
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and long-term outcomes in patients with peripartum cardiomyopathy (PPCM) receiving left ventricular assist devices (LVAD).
Berliner D; Li T; Mariani S; Hamdan R; Hanke J; König T; Pfeffer TJ; Abou-Moulig V; Dogan G; Hilfiker-Kleiner D; Haverich A; Bauersachs J; Schmitto JD
Artif Organs; 2023 Feb; 47(2):417-424. PubMed ID: 36113950
[TBL] [Abstract][Full Text] [Related]
20. A case of left ventricular assist device application for chemotherapy-related cardiomyopathy caused by trastuzumab and anthracycline.
Inui T; Kohno H; Matsuura K; Ueda H; Tamura Y; Watanabe M; Inage Y; Yakita Y; Matsumiya G
J Artif Organs; 2020 Sep; 23(3):270-274. PubMed ID: 31897739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
